SPARC is expressed in renal interstitial fibrosis and in renal vascular injury

Kidney International

Volumn 50, Issue 6, 1996, Pages 1978-1989

  Pichler, Raimund H ^b   Hugo, Christian ^b   Shankland, Stuart J ^b   Reed, May J ^b   Bassuk, James A ^b   Andoh, Takeshi F ^b   Lombardi, Donna M ^b   Schwartz, Stephen M ^b   Bennett, William M ^b   Alpers, Charles E ^b   Sage, E Helene ^b   Johnson, Richard J ^b   Couser, William G ^a  

^a Division of Nephrology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEYMANN NEPHRITIS; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 10544241188     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.520     Document Type: Article

References (56)

1. BOHLE A, GLOMB D, GRUND KE, MACKENSEN S: Correlations between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephroltic syndrome and in focal sclerosing glomerulonephritis. Virchow Arch 376:221-232, 1977
2. BOHLE A, GRUND KE, MACKENSEN S, TOLON M: Correlations between renal interstitium and level of serum creatinine. Morphometric investigations of biopsies in perimembranous glomerulonephritis. Virchow Arch 373:15-22, 1977
3. SCHWARTZ MM, FENNELL JS, LEWIS EJ: Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 13:534-547, 1982
4. ALEXPOULOS E, SERON D, HARTLEY RB, CAMERON JS: Lupus nephritis: Correlation of interstitial cells with glomerular function. Kidney Int 37:100-109, 1990
5. WEHRMANN M, BOHLE A, BOGENSCHÜTZ O, EISSELE R, FREISLEDERER A, ÖHLSCHLEGEL C, SCHUMM G, BATZ C, GÄRTNER H-V: Long term prognosis of chronic idiopathic membranous glomerulnephritis. An analysis of 334 cases with particular regard to tubulointerstitial changes. Clin Nephrol 31:67-76, 1989
6. MACKENSEN S, GRUND KE, SINDJIC M, BOHLE A: Influence of the renal cortical interstitium on the serum creatinine concentration and serum creatinine clearance in different chronic sclerosing interstitial nephritides. Nephron 24:30-34, 1979
7. MARCUSSEN N, OLSEN TS: Atubular glomeruli in patients with chronic pyelonephritis. Lab Invest 62:467-473, 1990
8. LANE TF, SAGE EH: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8:163-173, 1994
9. REED MJ, PUOLAKKAINEN PA, LANE TF, DICKERSON D, BORNSTEIN P, SAGE EH: Expression of SPARC and thrombospondin-1 in wound repair: Immunolocalization and in situ hybridization. J Histochem Cytochem 41:1467-1477, 1993
10. 2+ -dependent binding to the extracellular matrix. J Cell Biol 109:341-356, 1989
11. FUNK SE, SAGE EH: Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 154:53-63, 1993
12. SAGE EH: Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cell's in vitro. Biochem Cell Biol 70:579-592, 1992
13. HASSELAAR P, SAGE EH: SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49:272-283, 1992
14. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:2648-2652, 1991
15. JOHNSON RJ, RAINES E, FLOEGE J, YOSHIMURA A, PRITZI P, ALPERS CE, ROSS R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibodies to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
16. BOWEN-POPE DF, SEIFERT RA, ROSS R: The platelet-derived growth factor receptor, in Control of Animal Cell Proliferation, edited by BOYNTON AL, LEFFERT HL, New York, Academic Press, 1985,
17. HASSELAAR P, LOSKUTOFF DJ, SAWDEY M, SAGE EH: SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells. J Biol Chem 266:13178-13184, 1991
18. LANE TF, IRUELA-ARISPE ML, SAGE EH: Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 267:16736-16745, 1992
19. TREMBLE PM, LANE TF, SAGE EH, WERB Z: SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121:1433-1444, 1993
20. ALOUSI MA, POST RS, HEYMANN W: Experimental autoimmune nephrosis in rats. Am J Pathol 54:47-71, 1969
21. SALANT DJ, DARBY C, COUSER WG: Experimental membranous glomerulonephritis in rats: Quantitative studies of glomerular immune deposit formation in isolated gomeruli and whole animals. J Clin Invest 66:71-81, 1980
22. PERKINSON DT, BAKER PJ, COUSER WG, JOHNSON RJ, ADLER S: Membrane attack complex in experimental glomerular injury. Am J Pathol 120:121-128, 1985
23. BURDMANN EA, YOUNG B, ANDOH TF, EVANS A, ALPERS CE, LINDSLEY J, JOHNSON RJ, COUSER W, BENNETT WM: Mechanisms of cyclosporine-induced interstitial fibrosis. Transplant Proc 26:2588-2589, 1994
24. FLOEGE J, BURNS MW, ALPERS CE, YOSHIMURA A, PRITZL P, GORDON K, SEIFERT RA, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
25. DAEMEN MJAP, LOMBARDI DM, BOSMAN FT, SCHWARTZ SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-456, 1991
26. JOHNSON RJ, GARCIA RL, PRITZL P, ALPERS CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369-374, 1990
27. FLOEGE J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS C, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
28. FLOEGE J, BURNS MW, ALPERS CE, YOSHIMURA A, PRITZL P, GORDON K, SEIFERT RA, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
29. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RGK, PHILLIPS PE, PRITZL P, GOWN A, ROSS R, BOWEN-POPE DF, JOHNSON RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Nat Acad Sci USA 88:6560-6564, 1991
30. 2+ -binding EF-hand sequence. J Cell Biochem 57:127-140, 1995
31. BASSUK JA, BANEYX F, VERNON R, FUNK SE, SAGE EH: Expression of biologically active human SPARC in Escherichia coli. Arch Biochem Biophys 325:8-19, 1996
32. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
33. SKALLI O, ROPRAZ P, TRZECIAK A, BENZONANA G, GILLESSEN D, GABBIANI G: A monoclonal antibody against smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
34. PICHLER RH, BASSUK JA, HUGO C, REED M, ENG E, GORDON KL, PIPPIN J, ALPERS CE, COUSER WG, SAGE EH, JOHNSON RJ: SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits PDGF-mediated mesangial cell proliferation in vitro. Am J Pathol 148:1153-1167, 1996
35. HOLLAND PWH, HARPER SJ, MCVEY JH, HOGAN BLM: In vivo expression of mRNA for the Ca-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol 105:473-482, 1987
36. FLOEGE J, ALPERS CE, SAGE EH, PRITZL P, GORDON K, JOHNSON RJ, COUSER WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 67:486-497, 1992
37. LEMLEY KV, KRIZ W: Anatomy of the renal interstitium. Kidney Int 39:370-381, 1991
38. YEE J, KUNCIO GS, NEILSON EG: Tubulointerstitial injury following glomerulonephritis. Semin Nephrol 11:361-366, 1991
39. SEPPA HEJ, YAMADA KM, SEPPA SI, SILVER MH, KLEIMANN HK, SCHIFFMANN E: The cell binding fragment of fibronectin is chemotactic for fibroblasts. Cell Biol Int Rep 5:813-819, 1981
40. POSTLETHWAITE AE, SEYER JM, KANG AH: Chemotactic attraction of human fibrobasts to type I, II, III collagens and collagen-derived peptides. Proc Natl Acad Sci USA 75:871-875, 1978
41. WAHL LM, WINTER CC: Regulation of guinea pig macrophage collagenase production by dexamethasone and colchicine. Arch Biochem Biophys 230:661-667, 1984
42. FLOEGE J, ALPERS CE, BURNS MW, PRITZL P, GORDON K, COUSER WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497, 1992
43. TERMINE JD, KLEINMAN HK, WHITSON SM, CONN KM, MCGARVEY ML, MARTIN GR: Osteonectin, a bone-specific protein linking mineral to collagen. Cell 25:99-105, 1981
44. FRIZELL E, LIU SL, ABRAHAM A, OZAKI I, EGHBALI M, SAGE EH, ZERN MA: Expression of SPARC in normal and fibrotic livers. Hepatology 21:847-954, 1995
45. GILBERT RE, MCNALLY PG, COX A, DZIADEK M, RUMBLE J, COOPER M, JERUMS G: SPARC gene expression is reduced in early diabetes-related kidney growth. Kidney Int 48:1216-1225, 1995
46. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
47. NICOLIC-PATERSON DJ, LAN HY, ATKINS RC: Macrophages in renal injury. Kidney Int 45(Suppl 45):S79-S82, 1994
48. ALPERS CE, SEIFERT RA, HUDKINS KL, JOHNSON RJ, FB-PD: PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int 43:286-294, 1993
49. TANG WW, TARPLEY JE, VAN GY, QI M: PDGF-B is associated with myofibroblast formation in anti-GBM Ab tubulointerstitial nephritis (TIN). Exogenous PDGF-BB induces tubulointerstitial fibrosis. (abstract) J Am Soc Nephrol 6:913, 1995
50. RAINES EW, LANE TF, IRUELA-ARISPE ML, ROSS R, SAGE EH: The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89:1281-1285, 1992
51. KITAMURA A, KITAMURA M, NAGASAWA R, MARUYAMA N, MITARAI T, TAKAHASHI T, ISODA K: Renal fibroblasts are sensitive to growth repressing and matrix-reducing factors from activated lymphocytes. Clin Exp Immunol 91:516-520, 1993
52. KUHN C, MASON RJ: Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 147:1759-1769, 1995
53. ROSS R, RAINES EW, BOWEN-POPE DF: The biology of platelet-derived growth factor. Cell 46:155-169, 1986
54. GRIFFIN SA, BROWN WCB, MACPHERSON F, MCGRATH JC, WILSON VG, KORSGAARD N, MULVANY MJ, LEVER AF: Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension 17:626-635, 1991
55. TURLA MB, THOMPSON MM, CORJAY MH, OWENS GK: Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Circ Res 68:288-299, 1990
56. NAFTILAN AJ, PRATT RE, DZAU VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-1424, 1989